Taken together, these data suggest that DKG treatment promotes the accumulation of succinate and fumarate, resulting in HIF-1α induction and changes in subsequent transcriptional reprogramming and thereby impacting multiple cellular processes in BC cells. The gene discussed is HIF1A; the disease is breast cancer.